The aim of this study was to retrospectively evaluate the direct costs of OSCC treatment and postsurgical surveillance in a tertiary hospital in northeast Italy. Sixty-three consecutive patients surgically treated for primitive OSCC at S. Orsola Hospital in Bologna (Italy) between January 2018 and January 2020 were analyzed. Billing records of the Emilia Romagna healthcare system and institutional costs were used to derive specific costs for the following clinical categories: operating theatre costs, intensive and ordinary hospitalization, radiotherapy, chemotherapy, postsurgical complications, visits, and examinations during the follow-up period. The study population comprised 17 OSCC patients classified at stage I, 14 at stage II, eight at stage III, and 24 at stage IV. The estimated mean total direct cost for OSCC treatment and postsurgical surveillance was €26 338.48 per patient (stage I: €10 733, stage II: €19 642.9, stage III: €30 361.4, stage IV: €39 957.2). An advanced diagnosis (stages III and IV), complex surgical procedure, and loco-regional recurrences resulted in variables that were significantly associated with a higher cost of OSCC treatment and postsurgical surveillance. Redirection of funds used for OSCC treatment to screening measures may be an effective strategy to improve overall health outcomes and optimize national health resources.

Gissi D.B., Suarez-Fernandez C., Rossi R., Vitali F., Marzi Manfroni A., Gabusi A., et al. (2024). Direct healthcare costs of oral cancer: A retrospective study from a tertiary care center. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 52(5), 630-635 [10.1016/j.jcms.2024.03.002].

Direct healthcare costs of oral cancer: A retrospective study from a tertiary care center

Gissi D. B.;Rossi R.;Vitali F.;Marzi Manfroni A.;Gabusi A.;Morandi L.;Montebugnoli L.;Foschini M. P.;Tarsitano A.
2024

Abstract

The aim of this study was to retrospectively evaluate the direct costs of OSCC treatment and postsurgical surveillance in a tertiary hospital in northeast Italy. Sixty-three consecutive patients surgically treated for primitive OSCC at S. Orsola Hospital in Bologna (Italy) between January 2018 and January 2020 were analyzed. Billing records of the Emilia Romagna healthcare system and institutional costs were used to derive specific costs for the following clinical categories: operating theatre costs, intensive and ordinary hospitalization, radiotherapy, chemotherapy, postsurgical complications, visits, and examinations during the follow-up period. The study population comprised 17 OSCC patients classified at stage I, 14 at stage II, eight at stage III, and 24 at stage IV. The estimated mean total direct cost for OSCC treatment and postsurgical surveillance was €26 338.48 per patient (stage I: €10 733, stage II: €19 642.9, stage III: €30 361.4, stage IV: €39 957.2). An advanced diagnosis (stages III and IV), complex surgical procedure, and loco-regional recurrences resulted in variables that were significantly associated with a higher cost of OSCC treatment and postsurgical surveillance. Redirection of funds used for OSCC treatment to screening measures may be an effective strategy to improve overall health outcomes and optimize national health resources.
2024
Gissi D.B., Suarez-Fernandez C., Rossi R., Vitali F., Marzi Manfroni A., Gabusi A., et al. (2024). Direct healthcare costs of oral cancer: A retrospective study from a tertiary care center. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 52(5), 630-635 [10.1016/j.jcms.2024.03.002].
Gissi D.B.; Suarez-Fernandez C.; Rossi R.; Vitali F.; Marzi Manfroni A.; Gabusi A.; Morandi L.; Balbi T.; Montebugnoli L.; Foschini M.P.; Tarsitano A....espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/979635
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact